Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Angell

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Gene Therapy|October 7, 2005
A replication competent lentivirus (RCL) assay for equine infectious anaemia virus (EIAV)-based lentiviral vectorsJ Miskin, D Chipchase, J Rohll, et al.
British Journal of Pharmacology|May 4, 2013
Discovery of GW870086: a potent anti-inflammatory steroid with a unique pharmacological profileI J Uings, D Needham, J Matthews, et al.
Radiology|November 1, 1983
Internal derangement of the temporomandibular joint: detection by single-photon emission computed tomography. Work in progressB D Collier, G F Carrera, E J Messer, et al.
Nanomaterials (Basel, Switzerland)|September 27, 2024
Targeting Myeloid-Derived Suppressor Cells via Dual-Antibody Fluorescent Nanodiamond ConjugateColin D Angell, Gabriella Lapurga, Steven H Sun, et al.
Plos One|June 29, 2023
Expression of microRNAs and their target genes in melanomas originating from gynecologic sitesMallory J DiVincenzo, Colin D Angell, Lorena P Suarez-Kelly, et al.
Melanoma Research|January 30, 2025
A comparison of myeloid-derived suppressor cell populations in patients with ulcerated vs non-ulcerated melanoma receiving immune checkpoint blockadeColin D Angell, Steven H Sun, Gabriella Lapurga, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2007
Biphenyl amide p38 kinase inhibitors 2: Optimisation and SARRichard M Angell, Tony D Angell, Paul Bamborough, et al.
Bioorganic & Medicinal Chemistry Letters|July 8, 2008
Biphenyl amide p38 kinase inhibitors 4: DFG-in and DFG-out binding modesRichard M Angell, Tony D Angell, Paul Bamborough, et al.
Cancer Immunology, Immunotherapy : CII|August 1, 2023
BTK inhibition potentiates anti-PD-L1 treatment in murine melanoma: potential role for MDSC modulation in immunotherapySteven H Sun, Colin D Angell, Himanshu Savardekar, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Gene Therapy|October 7, 2005
A replication competent lentivirus (RCL) assay for equine infectious anaemia virus (EIAV)-based lentiviral vectorsJ Miskin, D Chipchase, J Rohll, et al.
British Journal of Pharmacology|May 4, 2013
Discovery of GW870086: a potent anti-inflammatory steroid with a unique pharmacological profileI J Uings, D Needham, J Matthews, et al.
Radiology|November 1, 1983
Internal derangement of the temporomandibular joint: detection by single-photon emission computed tomography. Work in progressB D Collier, G F Carrera, E J Messer, et al.
Nanomaterials (Basel, Switzerland)|September 27, 2024
Targeting Myeloid-Derived Suppressor Cells via Dual-Antibody Fluorescent Nanodiamond ConjugateColin D Angell, Gabriella Lapurga, Steven H Sun, et al.
Plos One|June 29, 2023
Expression of microRNAs and their target genes in melanomas originating from gynecologic sitesMallory J DiVincenzo, Colin D Angell, Lorena P Suarez-Kelly, et al.
Melanoma Research|January 30, 2025
A comparison of myeloid-derived suppressor cell populations in patients with ulcerated vs non-ulcerated melanoma receiving immune checkpoint blockadeColin D Angell, Steven H Sun, Gabriella Lapurga, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2007
Biphenyl amide p38 kinase inhibitors 2: Optimisation and SARRichard M Angell, Tony D Angell, Paul Bamborough, et al.
Bioorganic & Medicinal Chemistry Letters|July 8, 2008
Biphenyl amide p38 kinase inhibitors 4: DFG-in and DFG-out binding modesRichard M Angell, Tony D Angell, Paul Bamborough, et al.
Cancer Immunology, Immunotherapy : CII|August 1, 2023
BTK inhibition potentiates anti-PD-L1 treatment in murine melanoma: potential role for MDSC modulation in immunotherapySteven H Sun, Colin D Angell, Himanshu Savardekar, et al.
Pageof 4